Renal/ureteral calculi causing acute flank pain; calcium oxalate most common.
Also known as: urolithiasis, kidney stones, nephrolithiasis, ureterolithiasis, renal colic
Overview
Formation of crystalline aggregates (calculi) within the urinary tract — kidneys, ureters, bladder, or urethra. Acute presentations are dominated by ureteral stones causing renal colic, with calcium oxalate stones accounting for ~75% of all calculi.
Epidemiology
Lifetime prevalence ~10% in men, ~7% in women. Peak incidence ages 20-50. Recurrence ~50% within 10 years without prevention. Rising in women and adolescents over recent decades.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Urolithiasis (Kidney Stones) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Recurrent UTIs with urease-producing organisms (Proteus, Klebsiella) — struvite stones
Crohn disease, malabsorption, bariatric surgery (enteric hyperoxaluria)
Family history, obesity, diabetes, hot climate
Pathophysiology
Stone formation requires urinary supersaturation of stone-forming salts (calcium, oxalate, uric acid) plus inadequate inhibitors (citrate, magnesium). Crystal nucleation occurs on tubular cells (Randall plaques) or in tubular lumens. Growing stones obstruct the ureter, causing distention, prostaglandin release, smooth muscle spasm, and pain referred along splanchnic nerves (T11-L1).
Clinical presentation
Symptoms
Sudden severe colicky flank pain radiating to groin/testicle/labia
Patient writhing, unable to find comfortable position (contrast with peritonitis where patients lie still)
Nausea and vomiting
Dysuria, urinary frequency/urgency if stone in distal ureter near bladder
Gross hematuria in 30-40%, microscopic in ~85%
Signs / physical exam
CVA tenderness (often mild despite severe pain)
Patient appears restless and uncomfortable
Vital signs may show mild tachycardia, hypertension from pain
Fever raises concern for obstructed infected system (urologic emergency)
Classic findings
Writhing patient with acute severe flank pain radiating to groin + hematuria = textbook ureteral stone.
Ruptured abdominal aortic aneurysm — Older patients, hypotension, pulsatile mass; consider in older patients with first-ever 'stone' pain
Ovarian torsion / ectopic pregnancy — Women of reproductive age; pelvic exam, beta-hCG, transvaginal US
Appendicitis — Right-sided pain migrating to RLQ, fever, leukocytosis, may mimic right ureteral stone
Renal infarction — Risk factors for embolism (Afib, endocarditis); elevated LDH; CT with contrast diagnostic
Musculoskeletal pain — Reproducible with palpation, recent trauma or activity, normal UA
Diagnostic workup
Diagnostic criteria
CT-confirmed urinary tract calculus with consistent clinical presentation. Size and location predict spontaneous passage: <5 mm pass ~80%, 5-10 mm ~50%, >10 mm rarely; distal ureteral stones pass more often than proximal.
Labs
Urinalysis with microscopy — hematuria (gross or microscopic), pH (acidic favors uric acid; alkaline favors struvite, calcium phosphate), crystals
Urine culture if pyuria or fever
BMP — Ca, creatinine, electrolytes
CBC — leukocytosis suggests infection
Beta-hCG in women of reproductive age (before imaging)
Stone analysis when stone retrieved
Metabolic workup (24-h urine for Ca, oxalate, citrate, uric acid, Na, volume) for recurrent stones, single kidney, or first stone in child
Imaging
Non-contrast CT abdomen/pelvis (low-dose) — gold standard; identifies stones >1 mm, hydronephrosis, alternative diagnoses
Renal ultrasound — first-line in pregnancy and children; reasonable initial test in adults to detect hydronephrosis (lower sensitivity for small ureteral stones)
KUB plain film — limited; misses radiolucent uric acid stones
MR urography — alternative in pregnancy when US insufficient
Diagnostic algorithm
Stone Type
Prevalence
Urine pH
Crystals
Prevention
Calcium oxalate
~75%
Variable
Envelope/dumbbell-shaped
Hydration, thiazide, citrate, normal Ca diet
Calcium phosphate
~10%
Alkaline (>6.5)
Amorphous, wedge-shaped
Treat distal RTA, hyperparathyroidism
Uric acid
~10%
Acidic (<5.5)
Rhomboid/needle (radiolucent)
Alkalinize urine (K-citrate), allopurinol
Struvite (Mg-NH4-PO4)
~5-10%
Alkaline (>7)
Coffin-lid
Treat UTI, complete surgical removal
Cystine
<1%
Acidic
Hexagonal
Hydration, alkalinize, tiopronin/penicillamine
Kidney stone types with characteristic urine pH, crystal morphology, and prevention strategies.
Treatment
First-line
Pain control — NSAIDs (ketorolac IV/IM, ibuprofen) are first-line; superior to opioids and reduce ureteral spasm; AVOID in CKD, dehydration, or single kidney
Opioids (morphine, hydromorphone) as second-line or adjunctive analgesia
Antiemetics (ondansetron, metoclopramide)
IV fluids only if dehydrated — aggressive forced diuresis does not promote passage
Medical expulsive therapy (MET): alpha-blocker — tamsulosin 0.4 mg daily — for ureteral stones 5-10 mm; modest benefit
Second-line / adjunct
Urgent urologic intervention (within 24-48 h) if: obstructed infected system (urosepsis), single kidney with obstruction, refractory pain/vomiting, AKI from obstruction
Percutaneous nephrostomy or ureteral stent for emergent decompression
Definitive treatment options: shock wave lithotripsy (SWL) for stones <2 cm, ureteroscopy with laser lithotripsy (preferred for distal/large stones), percutaneous nephrolithotomy (PCNL) for staghorn or >2 cm renal stones
Prevention strategies based on stone type:
Calcium stones: high fluid intake (>2.5 L/day urine output), normal dietary calcium, low sodium, low animal protein, thiazide (HCTZ, chlorthalidone, indapamide) for hypercalciuria, potassium citrate for hypocitraturia
Uric acid stones: alkalinize urine (potassium citrate to pH 6.5-7), allopurinol if hyperuricosuria
Cystine stones: aggressive hydration, alkalinization, tiopronin or D-penicillamine for refractory
Struvite stones: complete stone removal + treat infection (urease inhibitor acetohydroxamic acid in select cases)
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.